ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea · Delayed Price · Currency is KRW 729.00
-34.00 (-4.46%)
At close: May 29, 2026
KOSDAQ:034940 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -4,727 | -6,806 | -9,605 | -10,514 | 560.69 | -8,044 |
Depreciation & Amortization | 2,413 | 2,432 | 2,389 | 2,387 | 2,388 | 2,893 |
Loss (Gain) From Sale of Assets | -2,547 | -1,544 | -293.83 | -85.73 | - | -8.72 |
Asset Writedown & Restructuring Costs | 1,129 | 1,129 | 246.28 | 1,989 | 107.1 | 1,938 |
Loss (Gain) From Sale of Investments | -484.89 | -450.84 | 2.95 | -171.99 | -235.85 | -1,605 |
Loss (Gain) on Equity Investments | 0.93 | -7.09 | -14.78 | -19.87 | 4.83 | -17.96 |
Provision & Write-off of Bad Debts | -189.11 | -90.71 | 504.79 | 202.2 | -230.01 | 269.87 |
Other Operating Activities | 3,740 | 3,933 | 2,666 | 4,384 | 1,864 | 3,899 |
Change in Accounts Receivable | 290.33 | 450.3 | 1,543 | 2,287 | -2,644 | 400.47 |
Change in Inventory | 945.7 | 700.84 | 596.73 | -2,212 | -549.25 | 2,292 |
Change in Accounts Payable | -262.04 | -1,373 | -646.98 | 507.62 | 1,304 | 81.5 |
Change in Other Net Operating Assets | -3,828 | -2,553 | -1,856 | -228.1 | -4,012 | -3,580 |
Operating Cash Flow | -3,518 | -4,180 | -4,468 | -1,475 | -1,443 | -1,480 |
Capital Expenditures | -2,024 | -1,986 | -551.31 | -831.13 | -2,782 | -3,544 |
Sale of Property, Plant & Equipment | 5,071 | 2,612 | 481.47 | 128.61 | - | 14.55 |
Sale (Purchase) of Intangibles | -12.99 | -36.41 | -229.11 | -111.52 | -140.19 | -319.99 |
Investment in Securities | 1,546 | 3,151 | -1,159 | 1,944 | 1,479 | 1,566 |
Other Investing Activities | 78.87 | 189.62 | -343.71 | -398.94 | -110.22 | 417.53 |
Investing Cash Flow | 4,658 | 3,931 | -1,802 | 731.38 | -1,553 | -1,866 |
Long-Term Debt Issued | - | 30,166 | 9,630 | 15,349 | 7,658 | 9,344 |
Long-Term Debt Repaid | - | -28,910 | -3,406 | -17,012 | -5,863 | -4,621 |
Net Debt Issued (Repaid) | 1,399 | 1,256 | 6,224 | -1,662 | 1,795 | 4,723 |
Other Financing Activities | -698 | -734 | -32 | -27.22 | 11.51 | 101.29 |
Financing Cash Flow | 700.61 | 521.63 | 6,192 | -1,690 | 1,807 | 4,825 |
Foreign Exchange Rate Adjustments | 0.69 | -45.09 | 127.94 | -44.95 | -33.84 | 106.45 |
Net Cash Flow | 1,842 | 227.59 | 50.04 | -2,478 | -1,223 | 1,585 |
Free Cash Flow | -5,542 | -6,165 | -5,019 | -2,306 | -4,225 | -5,024 |
Free Cash Flow Margin | -9.30% | -10.39% | -8.01% | -3.66% | -6.13% | -8.73% |
Free Cash Flow Per Share | -186.36 | -199.01 | -162.01 | -74.45 | -136.37 | -162.17 |
Cash Interest Paid | 1,088 | 1,071 | 1,026 | 913.95 | 564.55 | 287.07 |
Cash Income Tax Paid | 1.69 | -3.27 | 14.42 | -10.98 | -45.22 | - |
Levered Free Cash Flow | -4,925 | -5,338 | -894.16 | -850.27 | -3,337 | -3,096 |
Unlevered Free Cash Flow | -4,162 | -4,594 | -197.11 | -238.19 | -2,914 | -2,861 |
Change in Working Capital | -2,854 | -2,775 | -363.43 | 354.91 | -5,902 | -805.67 |